Oppenheimer Asset Management Inc. Has $857,000 Stock Position in Option Care Health, Inc. (NASDAQ:OPCH)

Oppenheimer Asset Management Inc. decreased its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 39.5% during the 4th quarter, Holdings Channel reports. The institutional investor owned 36,952 shares of the company’s stock after selling 24,086 shares during the period. Oppenheimer Asset Management Inc.’s holdings in Option Care Health were worth $857,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Westfield Capital Management Co. LP lifted its position in Option Care Health by 10.2% during the 3rd quarter. Westfield Capital Management Co. LP now owns 6,492,152 shares of the company’s stock worth $203,204,000 after buying an additional 599,589 shares in the last quarter. Global Alpha Capital Management Ltd. lifted its position in Option Care Health by 108.3% during the 3rd quarter. Global Alpha Capital Management Ltd. now owns 49,818 shares of the company’s stock worth $1,559,000 after buying an additional 25,905 shares in the last quarter. Graypoint LLC acquired a new position in Option Care Health during the 4th quarter worth about $1,161,000. Victory Capital Management Inc. lifted its position in Option Care Health by 4,432.8% during the 3rd quarter. Victory Capital Management Inc. now owns 1,621,593 shares of the company’s stock worth $50,756,000 after buying an additional 1,585,818 shares in the last quarter. Finally, Barclays PLC lifted its position in Option Care Health by 180.1% during the 3rd quarter. Barclays PLC now owns 310,194 shares of the company’s stock worth $9,708,000 after buying an additional 199,454 shares in the last quarter. Institutional investors and hedge funds own 98.05% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on the stock. UBS Group assumed coverage on shares of Option Care Health in a research report on Thursday, December 5th. They set a “neutral” rating and a $26.00 target price on the stock. Bank of America upgraded shares of Option Care Health from a “neutral” rating to a “buy” rating and upped their target price for the company from $26.00 to $33.00 in a research report on Monday, January 13th. Barrington Research upped their target price on shares of Option Care Health from $33.00 to $38.00 and gave the company an “outperform” rating in a research report on Thursday, February 27th. JMP Securities restated a “market outperform” rating and set a $30.00 target price (down from $31.00) on shares of Option Care Health in a research report on Friday, January 10th. Finally, JPMorgan Chase & Co. upped their target price on shares of Option Care Health from $38.00 to $40.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. Two analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $32.88.

Option Care Health Stock Performance

Shares of NASDAQ:OPCH opened at $34.12 on Wednesday. The company has a market capitalization of $5.81 billion, a price-to-earnings ratio of 28.67, a P/E/G ratio of 2.30 and a beta of 1.35. The firm’s 50 day simple moving average is $29.15 and its 200 day simple moving average is $28.09. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. Option Care Health, Inc. has a fifty-two week low of $21.39 and a fifty-two week high of $34.57.

Insider Activity at Option Care Health

In related news, insider Michael Bavaro sold 30,996 shares of the stock in a transaction that occurred on Friday, February 28th. The shares were sold at an average price of $33.26, for a total value of $1,030,926.96. Following the sale, the insider now directly owns 44,974 shares in the company, valued at $1,495,835.24. This trade represents a 40.80 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. 0.64% of the stock is currently owned by corporate insiders.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.